Neuren Pharmaceuticals
Home
About Us
Company Overview
Company Values
Board of Directors
Management
Corporate Directory
Product development
Product Development Pipeline
The science behind Neuren's products
Trofinetide (also known as NNZ-2566) in Rett Syndrome
Trofinetide (also known as NNZ-2566) in Fragile X Syndrome
NNZ-2591 in Phelan-McDermid syndrome
NNZ-2591 in Angelman syndrome
NNZ-2591 in Pitt Hopkins syndrome
NNZ-2591 in Prader-Willi syndrome
Investor Information
Welcome
Share Price Information
Shareholder Services
Investor presentations, audio, video
Corporate Governance
Analyst Coverage
Corporate Directory
News & Reports
ASX Announcements
Annual and Interim Reports
Scientific presentations
Email Alerts
Publications
Contact Us
Contact Us
Email Alerts
Home
>
News & Reports
>
Annual and Interim Reports
Font Smaller
Font larger
Print Page
Annual and Interim Reports
24-Feb-2022
Preliminary Final Report and 2021 Full Year Accounts
25-Aug-2021
Half Yearly Report and Accounts
24-Feb-2021
2020 Interactive Annual Report
24-Feb-2021
Preliminary Final Report and 2020 full year accounts
28-Aug-2020
2019 Interactive Annual Report
26-Aug-2020
Half Yearly Report and Accounts
4-May-2020
2018 Interactive Annual Report
26-Feb-2020
Appendix 4E and 2019 full year accounts
28-Aug-2019
Half Yearly Report and Accounts
27-Feb-2019
Preliminary Final Report and statutory accounts
31-Aug-2018
Half Yearly Report and Accounts
8-May-2018
2017 Interactive Annual Report
24-Aug-2017
Half Yearly Report and Accounts
1-May-2017
2016 Interactive Annual Report
23-Feb-2017
Preliminary Final Report
30-Aug-2016
Half Yearly Report and Accounts
1-May-2016
2015 Interactive Annual Report
25-Feb-2016
Appendix 4E and Financial Report 31 December 2015
25-Aug-2015
Half Yearly Report and Accounts 30 June 2015
25-Mar-2015
2014 Interactive Annual Report
25-Feb-2015
Neuren reports 2014 full-year financial results
25-Feb-2015
Preliminary Final Report and 2014 full year accounts
28-Aug-2014
Neuren reports 2014 half-year financial results
27-Aug-2014
Half Yearly Report and Accounts
27-Mar-2014
2013 Annual Report
29-Aug-2013
Half Yearly Report and Accounts
28-Mar-2013
Annual Report to shareholders
30-Aug-2012
Half Yearly Report and Accounts
30-Mar-2012
Neuren 2011 Annual Report
30-Aug-2011
Half Yearly Report and Accounts
31-Mar-2011
Annual Report to shareholders
26-Aug-2010
Half Yearly Report and Accounts
30-Mar-2010
Annual Report to shareholders
31-Aug-2009
Half Year Report and Accounts
31-Mar-2009
Annual Report to shareholders
29-Aug-2008
Half Yearly Report and Accounts
31-Mar-2008
Annual Report to shareholders